Ipilimumab and nivolumab/pembrolizumab in advanced hepatocellular carcinoma refractory to prior immune checkpoint inhibitors.

Jeffrey Sum Lung Wong,Gin Wai Kwok,Vikki Tang,Bryan Li,Roland Leung,Joanne Wing Yan Chiu,Ka Wing Ma,Wong Hoi She,Wing Yan Josephine Tsang,Tan To Cheung,Thomas Yau

Ipilimumab and nivolumab/pembrolizumab in advanced hepatocellular carcinoma refractory to prior immune checkpoint inhibitors.

2021

Jeffrey Sum Lung Wong
Gin Wai Kwok
Vikki Tang
Bryan Li
Roland Leung
Joanne Wing Yan Chiu
Ka Wing Ma
Wong Hoi She
Wing Yan Josephine Tsang
Tan To Cheung
Thomas Yau

330Background: Programmed cell death protein 1 (PD-1) pathway blockade with immune checkpoint inhibitors (ICI) is a standard therapy in advanced hepatocellular carcinoma (HCC) nowadays. No strategi...

Keywords:

Blockade
Refractory
Hepatocellular carcinoma
Ipilimumab
Cancer research
Pembrolizumab
Nivolumab
immune checkpoint inhibitors
Programmed cell death 1
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations